Surgery, radiotherapy or a combined modality for jugulotympanic paraganglioma of Fisch class C and D

Fulltext:
200416.pdf
Embargo:
until further notice
Size:
165.3Kb
Format:
PDF
Description:
publisher's version
Publication year
2018Source
Clinical Otolaryngology, 43, 6, (2018), pp. 1566-1572ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Otorhinolaryngology
Radiation Oncology
Internal Medicine
Journal title
Clinical Otolaryngology
Volume
vol. 43
Issue
iss. 6
Page start
p. 1566
Page end
p. 1572
Subject
Radboudumc 16: Vascular damage RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health SciencesAbstract
OBJECTIVES: To identify the risks associated with surgery, radiotherapy or a combined treatment approach for Fisch class C and D jugulotympanic paraganglioma, in order to develop an individualised approach for each patient depending on Fisch class, age, mutation presence, tumour size growth rate and presenting symptoms. DESIGN: A retrospective multicenter cohort study with all patient records of patients with a head and neck paraganglioma in the Radboudumc, Nijmegen and the St. Elisabeth Hospital, Tilburg, the Netherlands. MAIN OUTCOME MEASURES: Local control, cranial nerve damage, complications, function recovery. RESULTS: We found highest local control rates after tumour debulking with postoperative radiotherapy in case of residual tumour growth, referred to as the combined treatment group, (100%; n = 19), which was significantly higher than the surgical group (82%; n = 17; P = 0.00), but did not differ from the radiotherapy group (90%; n = 29). There were significantly less complications in the radiotherapy group, when compared to surgery (63 vs 27%; P = 0.002) and the combined group (44 vs 27%; P = 0.016). Furthermore,: using a logistic regression model, we found that pretreatment tumour growth was a negative predictor for post-treatment cranial nerve function recovery (OR = 50.178, P = 0.001), reducing the chance of symptom recovery (67.3% vs 35.7%) post-treatment. CONCLUSIONS: Radiotherapy should be the treatment of choice for the elderly. For younger patients, tumour debulking should be considered, with potential radiotherapy in case of residual tumour growth.
This item appears in the following Collection(s)
- Academic publications [227864]
- Electronic publications [107337]
- Faculty of Medical Sciences [86218]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.